Business Standard

Tuesday, December 24, 2024 | 02:43 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Here's why Mehul Kothari is bullish on Glenmark Pharma, Muthoot Finance

According to the technical analyst from Anand Rathi, Glenmark Pharma can surge to Rs 460, while Muthoot Finance can rally to Rs 1,175.

technicals
Premium

technicals

Mehul Kothari Mumbai
BUY
Glenmark
Target: Rs 460
Stop Loss: Rs 405

Glenmark Pharma has observed a steep fall of 49 per cent between July 2021 and June 2022. Since then the stock has been consolidating between Rs 360-400, and it has made a solid base near Rs 375 level.

On the weekly scale, the said counter has formed an Inverted Bullish Hammer near support zone along with weekly RSI (relative strength index) has formed an impulsive structure which is adding more confirmation for upside in coming days.

In line with above technical rationale Glenmark has broken its previous trading range of Rs 370-410 and closed

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in